Evolution of prostate cancer brachytherapy

被引：3

作者：

Hannoun-Levi, Jean-Michel ^{[1
]}

Chevallier, Daniel ^{[2
]}

Cosset, Jean-Marc ^{[3
]}

Gerbaulet, Alain ^{[4
]}

机构：

[1] Univ Nice Sophia, Dept Radiotherapie, Ctr Antoine Lacassagne, F-06189 Nice, France

[2] CHU Nice, Serv Chirurg Urol, F-06000 Nice, France

[3] Inst Curie, Dept Radiotherapie, Paris, France

[4] Inst Gustave Roussy, Dept Radiotherapie, F-94800 Villejuif, France

来源：

BULLETIN DU CANCER | 2012年 / 99卷 / 12期

关键词：

prostate cancer; brachytherapy; low-dose rate; high-dose rate; DOSE-RATE BRACHYTHERAPY; SOCIETY CONSENSUS GUIDELINES; EXTERNAL-BEAM RADIOTHERAPY; PHASE-II TRIAL; AMERICAN BRACHYTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; EXPERIENCE; MANAGEMENT; SURVIVAL;

D O I：

10.1684/bdc.2012.1668

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Curietherapy, more commonly named brachytherapy, is one of the oldest irradiation techniques used for prostate cancer. Prostate brachytherapy evolved according to the scientific and technological progress. After a historical reminder of the evolution of prostate brachytherapy, different technical aspects are discussed: low-dose rate brachytherapy using permanent or temporary implants, high-dose rate brachytherapy as well as new imaging modalities. Prostate brachytherapy indications are listed regarding to the evidence-based medicine data for low, intermediate and high risks prostate cancers. Potential indications and new research programs (focal therapy, high-dose rate, single-dose brachytherapy) are also presented.

引用

页码：1175 / 1181

页数：7

共 33 条

[1]

Albert JM, 2012, BRACHYTHERAPY

[2]

[Anonymous], 2012, GUIDE AFFECTION LONG

[3] Radium in the treatment of prostatic carcinoma [J].

Barringer, BS .

ANNALS OF SURGERY, 1924, 80 :881-884

[4] Which modality for prostate brachytherapy? [J].

Bossi, A. .

CANCER RADIOTHERAPIE, 2010, 14 (6-7) :488-492

[5]

Bowes D, 2012, BRACHYTHERAPY

[6] LONG-TERM OUTCOME AND TOXICITY OF SALVAGE BRACHYTHERAPY FOR LOCAL FAILURE AFTER INITIAL RADIOTHERAPY FOR PROSTATE CANCER [J].

Burri, Ryan J. ;

Stone, Nelson N. ;

Unger, Pam ;

Stock, Richard G. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (05) :1338-1344

[7]

Chauveinc L, 2004, Cancer Radiother, V8, P211, DOI 10.1016/j.canrad.2004.06.001

[8]

Cosset JM, 2006, B CANCER, V93, P761

[9] Selecting patients for exclusive permanent implant prostate brachytherapy: The experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients [J].

Cosset, Jean-Marc ;

Flam, Thierry ;

Thiounn, Nicolas ;

Gomme, Stephanie ;

Rosenwald, Jean-Claude ;

Asselain, Bernard ;

Pontvert, Dominique ;

Henni, Mehdi ;

Debre, Bernard ;

Chauveinc, Laurent .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (04) :1042-1048

[10] The role of brachytherapy in the definitive management of prostate cancer [J].

Crook, J. .

CANCER RADIOTHERAPIE, 2011, 15 (03) :230-237

← 1 2 3 4 →